Calpain dysregulation in Alzheimer's disease
1Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Ward 8-140, Chicago, IL 60611, USA.
ISRN Biochemistry
|May 14, 2015
Summary
Alzheimer's disease involves brain plaques and tangles, linked to calcium imbalance and calpain protease activation. This review explores calpains' role in Alzheimer's neurodegeneration mechanisms.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder in aging populations.
- AD pathology includes senile plaques, neurofibrillary tangles, and synaptic loss in the brain.
- Emerging evidence suggests a link between AD hallmarks and disrupted calcium homeostasis.
Purpose of the Study:
- To review the structure and regulation of calpains, a family of calcium-dependent cysteine proteases.
- To summarize the involvement of calpains in the neurodegenerative processes of Alzheimer's disease.
Main Methods:
- Literature review of existing studies on calpains and Alzheimer's disease.
- Analysis of data on calcium homeostasis and its relation to calpain activation in AD.
Main Results:
- Calpains are crucial for various cellular functions, including development and cell death.
- Dysregulation of calcium homeostasis in AD leads to abnormal calpain activation.
- Calpain activation is implicated in the molecular mechanisms underlying AD pathogenesis.
Conclusions:
- Calpains are key players in the neurodegenerative cascade of Alzheimer's disease.
- Understanding calpain's role offers potential therapeutic targets for AD treatment.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Caspases
14.6K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.6K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Amyloid Fibrils
13.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.1K


